Biotechnology - Asia-Pacific, Antibiotics and Infectious diseases


Popular Filters

TaiGen Biotech out-licenses China rights for nemonoxacin, to Zhejiang Medicine


Taiwan-based TaiGen Biotechnology and China's Zhejiang Medicine Company (SHA: 600216) have signed an…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyLicensingnemonoxacinPharmaceuticalTaiGen BiotecnologyZhejiang Medicine

Immuron joins academia for C. Difficile therapeutics


Australian biotechnology firm Immuron (ASX: IMC) has entered into a collaboration agreement with Australia’s…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyImmuronResearch

Back to top